The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 329:811-812 September 9, 1993 Number 11
NextNext

Reinfection with Multidrug-Resistant Tuberculosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Small, P. M.
To the Editor: In their report in the April 22 issue, Small et al.1 showed that exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis can occur either during therapy for the original infection or after therapy has been completed. They described three patients seropositive for human immunodeficiency virus (HIV) (Patients 8, 11, and 12) with drug-susceptible tuberculosis whose original tuberculosis strains became resistant to rifampin alone during therapy. This is an unusual observation. The first phenotypic change noted in virtually all persons infected with strains of tuberculosis that become drug resistant is resistance to isoniazid.

We have noted the acquisition of drug . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.